NDEWS Publications

United States Sentencing Commission - Synthetic Cannabinoids, Cathinones, and MDMA (April 18, 2017) - Written Testimony: Eric D. Wish, PhD, CESAR Director

Webinar: NDEWS Presents: Synthetic Drugs Threats in the United States: 2017 Update (February 2017)

Webinar: NDEWS Presents: Synthetic Drugs Threats in the United States (February 2016)

Fact Sheets/ Alerts

 

CDC: Acute Poisonings from Synthetic Cannabinoids- 50 U.S Toxicology Investigators Consortium Registry Sites, 2010-2015

NIDA Synthetic Cannabinoid Drug Information

DEA Synthetic Cannabinoid (K2/ Spice) Drug Information

Journal Articles

Metabolism and Toxiocological Analysis of Synthetic Cannabinoids in Biological Fluids and Tissues

Fatal Overdose from Synthetic Cannabinoids and Cathinones in Japan: Demographics and Autopsy Findings

Discriminative Stimulus Properties of Phytocannabinoids, Endocannabinoids, and Synthetic Cannabinoids

Effect of Synthetic Cannabinoids on Spontaneous Neuronal Activtiy: Evaluation Using Ca2+ Spiking and Multi-electrode Arrays

Other Resources

 
EMCDDA: Report on the risk assessment of N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA) in the framework of the Council Decision on new psychoactive substances (May 2018)

Synthetic Marijuana Use Increasing Among Homeless in Lexington, Ky.  (April 2017)

Genetic factors may contribute to adverse effects produced by synthetic cannabinoids (April 2017)

K2 spike in downtown Austin sends 33 to the hospital

Drug 85 Times as Potent as Marijuana Caused a 'Zombielike' State in Brooklyn (December 2016)

New Special Report: Synthetic Cannabinoids and Synthetic Cathinones Reported in NFLIS 2013-2015 (November 2016)

Designer Drug Update Summer 2016 Webinar: Novel Synthetic Cannabinoids and Designer Opioids Dominate the Market (August 2016)

K2 Overdoses Surge in New York: At Least 130 Cases This Week Alone

ARCHIVED FILES

 

Last modified
04/15/2019 - 10:55 am